Sexually Transmitted Infections

Sexually Transmitted Infections
Author: National Academies of Sciences, Engineering, and Medicine
Publisher:
Total Pages: 750
Release: 2021-12-24
Genre: Medical
ISBN: 9780309683951

One in five people in the United States had a sexually transmitted infection (STI) on any given day in 2018, totaling nearly 68 million estimated infections. STIs are often asymptomatic (especially in women) and are therefore often undiagnosed and unreported. Untreated STIs can have severe health consequences, including chronic pelvic pain, infertility, miscarriage or newborn death, and increased risk of HIV infection, genital and oral cancers, neurological and rheumatological effects. In light of this, the Centers for Disease Control and Prevention, through the National Association of County and City Health Officials, commissioned the National Academies of Sciences, Engineering, and Medicine to convene a committee to examine the prevention and control of sexually transmitted infections in the United States and provide recommendations for action. In 1997, the Institute of Medicine released a report, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Although significant scientific advances have been made since that time, many of the problems and barriers described in that report persist today; STIs remain an underfunded and comparatively neglected field of public health practice and research. The committee reviewed the current state of STIs in the United States, and the resulting report, Sexually Transmitted Infections: Advancing a Sexual Health Paradigm, provides advice on future public health programs, policy, and research.

Policing Methamphetamine

Policing Methamphetamine
Author: William Campbell Garriott
Publisher: NYU Press
Total Pages: 203
Release: 2011
Genre: Political Science
ISBN: 081473300X

In its steady march across the United States, methamphetamine has become, to quote former Attorney General Alberto Gonzales, OC the most dangerous drug in America.OCO As a result, there has been a concerted effort at the local level to root out the methamphetamine problem by identifying the people at its sourceOCothose known or suspected to be involved with methamphetamine. Government-sponsored anti-methamphetamine legislation has enhanced these local efforts, formally and informally encouraging rural residents to identify meth offenders in their communities. Policing Methamphetamine shows what happens in everyday lifeOCoand to everyday lifeOCowhen methamphetamine becomes an object of collective concern. Drawing on interviews with users, police officers, judges, and parents and friends of addicts in one West Virginia town, William Garriott finds that this overriding effort to confront the problem changed the character of the community as well as the role of law in creating and maintaining social order. Ultimately, this work addresses the impact of methamphetamine and, more generally, the war on drugs, on everyday life in the United States.

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 483
Release: 2017-09-28
Genre: Medical
ISBN: 0309459575

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.